Year archive

Pharmala Biotech Holdings Inc. — 2021 filings

All 21 regulatory filings released by Pharmala Biotech Holdings Inc. (MDMA) in 2021, sourced directly from the official regulator.

21 Filings

2021 Period

2021 filings (21)

Filing	Released	Lang
Decision Document (Final).pdf Regulatory Filings	2021-12-21	English
Escrow agreement.pdf Regulatory Filings	2021-12-21	English
Auditors' consent letter.pdf Regulatory Filings	2021-12-21	English
Final long form prospectus - English.pdf Regulatory Filings	2021-12-21	English
Non-issuer's submission to jurisdiction and appointment of agent.pdf Regulatory Filings	2021-12-21	English
Receipt for Amendment to Preliminary Prospectus.pdf Regulatory Filings	2021-11-26	English
Amendment to (or amended) preliminary long form prospectus - English.pdf Capital/Financing Update	2021-11-26	English
Other.pdf Regulatory Filings	2021-10-29	English
Other material contract(s).pdf Regulatory Filings	2021-10-05	English
Other material contract(s).pdf Regulatory Filings	2021-10-05	English
Other material contract(s).pdf Regulatory Filings	2021-10-05	English
Other material contract(s).pdf Regulatory Filings	2021-10-05	English
Other material contract(s).pdf Regulatory Filings	2021-10-05	English
Other material contract(s).pdf Regulatory Filings	2021-10-05	English
Preliminary Receipt.pdf Regulatory Filings	2021-09-01	English
Preliminary long form prospectus - English.pdf Capital/Financing Update	2021-08-31	English
Report of exempt distribution excluding schedule 1 of Form 5.pdf Regulatory Filings	2021-05-26	English
Report of exempt distribution excluding schedule 1 of Form 5.pdf Regulatory Filings	2021-02-16	English
Report of exempt distribution excluding schedule 1 of Form 5.pdf Regulatory Filings	2021-01-21	English
Report of exempt distribution excluding schedule 1 of Form 5.pdf Regulatory Filings	2021-01-21	English
Offering document - English.pdf Capital/Financing Update	2021-01-21	English